A Primer on Pre-Grant Opposition
Let’s dig into the intriguing patent grant procedures and the crucial role of pre-grant opponents in influencing the fate of...
Greetings from The IP Press!
We wish you a very Happy 2024!
This compilation contains the compilation of significant judgments of 2023 which are related to...
From an in-depth discussion on the terms of copyright and translations in India to the recent UK Supreme Court’s order regarding the patentability of...
ARTICLE | FinancePlus: NASH play Madrigal raises $500M, and updates from Regeneron, Thymmune, Harvard Medical School and more By BioCentury Staff
September 30, 2023 2:15...
ARTICLE | FinancePlus: Novartis sells front-of-eye portfolio to B&L, and updates from argenx, Black Diamond, KangaBio and more By BioCentury Staff
July 1, 2023 12:39 AM UTC
Despite...
ARTICLE | Management TracksPlus: Zimmermann named CBO at SonoThera and updates from Secretome, Healthcare, Ultima and Koneska By Richard Guy, Biopharma Analyst, and Gunjan Ohri,...
The rise of text and semantic search engines has made ecommerce and retail businesses search easier for its consumers. Search engines powered by unified...
BioNTech SE has completed construction at a German facility for making a key ingredient in its messenger-RNA vaccines, the sort of investment that pharma...
The Falsified Medicines Directive (2011/62/EU) (FMD) was introduced in 2011 with the aim of safeguarding the public against medicinal products within the EU whose...
In recent years, the title of leading filer of Australian patent applications has been hotly (though probably inadvertently) contested between Huawei Technologies Ltd...
Any drug or molecule is granted 20 years of patent protection, after expiration of which revenue for patented drug decreases sharply as generic substitutes...
